bpc 157 on gut health 🧬 BPC-157 Peptide Therapy BPC-157 and Gut Health: Why

In a 16-week study of nightly GHRH-(1-29) dosing in older adults, nocturnal growth-hormone output stayed elevated across the full treatment period and IGF-1 rose and remained above baseline, with no sign of the pituitary becoming desensitized to nightly stimulation over those 16 weeks (Khorram et al., 1997)

The absence of a Phase III trial isnt evidence of absence

This is why the 3045 minute pre-meal dosing window is critical it ensures the peptide is at peak concentration as food intake begins

The convenience of a fixed blend is also its limitation

HGH Fragment 176-191 has no comparable human data at all

Western blot Cells were harvested and proteins were extracted using cell lysis buffer supplemented with 0.3% phenylmethylsulfonyl fluoride and proteinase and phosphatase inhibitors